Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Forte Biosciences Inc (FBRX)

Forte Biosciences Inc (FBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Forte Biosciences Inc 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247 USA

www.fortebiorx.com Employees: 9 P: 310-618-6994

Description:

Forte Biosciences Inc. is a clinical stage, dermatology company. It engages in developing biotherapeutic, FB-401, for the treatment of inflammatory skin diseases which is in clinical stage. Forte Biosciences Inc., formerly known as Tocagen Inc., is based in Sherman Oaks, California.

Key Statistics

Overview:

Market Capitalization, $K 28,273
Enterprise Value, $K -8,857
Shares Outstanding, K 1,462
Annual Sales, $ 0 K
Annual Net Income, $ -31,480 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -8,390 K
EBIT, $ -35,630 K
EBITDA, $ -35,620 K
60-Month Beta 1.11
% of Insider Shareholders 9.60%
% of Institutional Shareholders 77.63%
Float, K 1,322
% Float 90.40%
Short Volume Ratio 0.58

Growth:

1-Year Return 4.54%
3-Year Return -65.15%
5-Year Return -39.47%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 97.27%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -4.54 on 11/14/24
Next Earnings Date 11/18/24
Earnings Per Share ttm -16.29
EPS Growth vs. Prev Qtr 32.74%
EPS Growth vs. Prev Year 30.15%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-25 on 08/28/24

FBRX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -151.43%
Return-on-Assets % -118.92%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.91
Book Value/Share 6.42
Interest Coverage -1.96
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar